Page 11234..10..»

Category Archives: Coronary Heart Diseases

Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused | TCRM – Dove Medical Press

Posted: November 19, 2019 at 8:44 am

Jing Tian,1 Jingjing Yan,2 Qing Zhang,1 Hong Yang,2 Xinlong Chen,1 Qiang Han,2 Rui Han,1 Jia Ren,1 Yanbo Zhang,2,3 Qinghua Han1 1Department of Cardiology, The 1st Hospital of Shanxi Medical University, Taiyuan, Shanxi Province 030001, Peoples Republic of China; 2Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi Province 030001, Peoples Republic of China; 3Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, Taiyuan, Shanxi Province 030001, Peoples Republic of China Correspondence: Qinghua HanDepartment of Cardiology, The 1st Hospital of Shanxi Medical University, 85 South Jiefang Road, Taiyuan, Shanxi Province 030001, Peoples Republic of ChinaTel +86 3100113031Fax +86 351 4867146Email syhqn@sohu.comYanbo ZhangDepartment of Health Statistics, School of Public Health, Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, Shanxi Medical University, 56 South XinJian Road, Taiyuan, Shanxi Province 030001, Peoples Republic of ChinaTel/fax +86 3543985051Email sxmuzyb@126.com Background: The re-hospitalization rate of patients with heart failure remains at a high level, and studies of the subject have focused mainly on event-time outcomes. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused | TCRM – Dove Medical Press

The Europe Remote Patient Monitoring Devices market is expected to reach US$ 432.58 Mn in 2027 from US$ 204.55 Mn in 2018 – Yahoo Finance

Posted: at 8:44 am

The market is estimated to grow with a CAGR of 9. 0% from 2019-2027. The growth of the market is driven by the factors such as rising cases of the chronic diseases such as heart and respiratory diseases and COPD and lung cancer among the countries such as UK and Germany among the other countries. Continue reading

Posted in Coronary Heart Diseases | Comments Off on The Europe Remote Patient Monitoring Devices market is expected to reach US$ 432.58 Mn in 2027 from US$ 204.55 Mn in 2018 – Yahoo Finance

Omega-3 Protects Against Cardiovascular Illness-related Death Without Risk Of Prostate Cancer – International Business Times

Posted: at 8:44 am

The facts about omega-3, whether in pill form or as food, can be a bit unclear if you read health and nutrition headlines.Many people get confused as to whether they should consume two to three servings of omega-3 rich fish per week or take them in pill form. This is why Intermountain Healthcare Heart Institute researchers continue to study health benefits, as well as risks, of this supplement. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Omega-3 Protects Against Cardiovascular Illness-related Death Without Risk Of Prostate Cancer – International Business Times

Treatment gaps exist for patients with peripheral arterial disease, 15-year study finds – News-Medical.net

Posted: at 8:44 am

Peripheral arterial disease (PAD) is a progressive and life-threatening form of atherosclerosis that narrows the arteries serving the legs, arms, chest, and abdominal organs. It affects more than 8.5 million people in the United States, including 10 to 20 percent of individuals over 60 years old. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Treatment gaps exist for patients with peripheral arterial disease, 15-year study finds – News-Medical.net

Omega-3 fights against heart diseases without elevating the risk of prostate cancer, finds study – TheHealthSite

Posted: at 8:44 am

Omega-3 is an important fat that is known to carry a number ofhealthbenefits, but whether it is essential in protecting an individual against heart diseases or not, has remained a question. Moreover, if Omega-3 increases the risk of prostate cancer is another question that researchers in a new study investigated. To answer the same, researchers at the Intermountain Healthcare Heart Institute researched the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and hearthealth Continue reading

Posted in Coronary Heart Diseases | Comments Off on Omega-3 fights against heart diseases without elevating the risk of prostate cancer, finds study – TheHealthSite

First it was pay and pensionsnow women have to mind the gender health gap – The Sun

Posted: at 8:44 am

AS women, we are accustomed to pain during periods, in the middle of our cycle and in pregnancy or childbirth. But what about the unexplained pain? Whether it is in the lower back or joints, in the pelvis or abdomen, headaches, or even heart pain, many predominantly female symptoms are blamed on stress or hormones. Continue reading

Posted in Coronary Heart Diseases | Comments Off on First it was pay and pensionsnow women have to mind the gender health gap – The Sun

Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019 | DNA RNA…

Posted: at 8:44 am

DetailsCategory: DNA RNA and CellsPublished on Monday, 18 November 2019 09:38Hits: 263 Single administration of CLBS16 durably improves heart function and symptoms with no cell-related adverse events CLBS16 cell therapy shows promise as a significant advancement in treatment of Coronary Microvascular Dysfunction (CMD), a condition that disproportionately afflicts women PHILADELPHIA, PA, USA I November 16, 2019 ICaladrius Biosciences, Inc. (Nasdaq: CLBS), a late-stage biopharmaceutical company focused on developing treatments for select cardiovascular diseases, along with researchers from Cedars-Sinai (Los Angeles), Mayo Clinic (Rochester, Minn.) and The Christ Hospital (Cincinnati), today presented results from the ESCaPE-CMD trial of Caladriuss autologous CD34+ cell therapy, CLBS16, at the American Heart Association Scientific Sessions 2019. Data showed highly statistically significant improvement in coronary flow reserve correlating with symptom relief for patients with coronary microvascular dysfunction after a single intracoronary injection of CLBS16 Continue reading

Posted in Coronary Heart Diseases | Comments Off on Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019 | DNA RNA…

Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Forecast (2019-2024) Report: By Regions, Type and Application with Sales and…

Posted: at 8:44 am

Cardio Vascular Diseases or CVD is the worlds leading cause of death in men and women and these deaths are due to heart failure, congenital heart disease, peripheral vascular disease, cardiomyopathy, coronary heart disease and stroke. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Forecast (2019-2024) Report: By Regions, Type and Application with Sales and…

Interim analysis from EMPRISE real-world study shows Jardiance decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and…

Posted: at 8:44 am

- This analysis on effectiveness also shows Jardiance (empagliflozin) was associated with a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors or GLP-1 receptor agonists - A second analysis on healthcare resource utilization shows Jardiance was associated with a reduced risk in all-cause hospitalizations compared with DPP-4 inhibitors RIDGEFIELD, Conn.and INDIANAPOLIS, Nov. 17,2019 /PRNewswire/ --A new interim analysis of three-year data from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) real-world study on effectiveness shows that Jardiance (empagliflozin) was associated with a decreased risk of hospitalization for heart failure and a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors and GLP-1 receptor agonists. The interim analysis included 190,000 adults in the U.S. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Interim analysis from EMPRISE real-world study shows Jardiance decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and…

Dont like to exercise? Heres what else you can do to stay fit – The Indian Express

Posted: at 8:44 am

From dancing to trekking and skipping, pick your favourite. (Source: Getty/Thinkstock) Not everyone is a fan of sweating it out in the gym. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Dont like to exercise? Heres what else you can do to stay fit – The Indian Express

Page 11234..10..»